Gotowe bibliografie tematyczne / Allogeneic hematopoietic cell transplantation

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji
  6. Raporty organizacyjne

Gotowa bibliografia na temat „Allogeneic hematopoietic cell transplantation”

Autor: Grafiati
Data publikacji: 2 czerwca 2025
Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Allogeneic hematopoietic cell transplantation”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Allogeneic hematopoietic cell transplantation"

1

Ruutu, Tapani, Christian Koenecke, and Grzegorz W. Basak. "Allogeneic hematopoietic stem cell transplantation and solid organ transplantation in the same patient." Cellular Therapy and Transplantation 4, no. 1-2 (2015): 14–18. http://dx.doi.org/10.18620/1866-8836-2015-4-1-2-14-18.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Taskhyngali, Nazgul. "Second hematopoietic stem cell transplantation in miltiple myeloma." Oncology.kz 3, no. 13 (2024): 26–29. https://doi.org/10.56598/2957-6377-2024-3-13-26-29.

Pełny tekst źródła
Streszczenie:
Autologous hematopoietic stem cell transplantation is a standard frontline therapy for multiple myeloma. Performing a second transplant after a relapse of multiple myeloma presents a therapeutic dilemma for doctors. The purpose of this study is to evaluate the effectiveness and feasibility of repeated autologous transplants and haploidentical/allogeneic transplants in patients with multiple myeloma. Methods. A retrospective analysis of the medical histories of patients who underwent transplantation of autologous hematopoietic stem cells with multiple myeloma at the National Cancer Research Cen
Style APA, Harvard, Vancouver, ISO itp.
3

Storb, R., and B. M. Sandmaier. "Nonmyeloablative allogeneic hematopoietic cell transplantation." Haematologica 101, no. 5 (2016): 521–30. http://dx.doi.org/10.3324/haematol.2015.132860.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Kai, Shunro, and Hiroshi Hara. "Allogeneic Hematopoietic Stem Cell Transplantation." Therapeutic Apheresis and Dialysis 7, no. 3 (2003): 285–91. http://dx.doi.org/10.1046/j.1526-0968.2003.00053.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Bertz, Hartmut. "Allogeneic hematopoietic stem cell transplantation." Current Opinion in Organ Transplantation 6, no. 3 (2001): 259. http://dx.doi.org/10.1097/00075200-200109000-00010.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Tabbara, Imad A., Kathy Zimmerman, Connie Morgan, and Zeina Nahleh. "Allogeneic Hematopoietic Stem Cell Transplantation." Archives of Internal Medicine 162, no. 14 (2002): 1558. http://dx.doi.org/10.1001/archinte.162.14.1558.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Eida, Elmansorry. "Kinetics of Lymphocytes Reconstitution Post Allogeneic Hematopoietic Stem Cell Transplantation: Two years of Follow-up." Alq J Med App Sci 5, no. 1 (2022): 166–71. https://doi.org/10.5281/zenodo.6374106.

Pełny tekst źródła
Streszczenie:
Background and aims. Allogeneic hematopoietic stem cells transplantation (HSCT) is strong curative treatment for several classes of immunodeficiency, metabolic disorders, and haematopoietic malignancies. Depending on HSCT procedure, thousands of patients could heal from their underlying disease. The ability of hematopoietic stem cells transplantation (HSCT) to cure is affected by variant factors. The objectives of this study were to analyze the kinetics of lymphocyte recovery at different time points after allogeneic hematopoietic stem cells transplantation and to correlate their recovery with
Style APA, Harvard, Vancouver, ISO itp.
8

Akhmedov, M. I., G. A. Klyasova, and E. N. Parovichnikova. "Infectious complications and their contributing risk factors after allogeneic hematopoietic stem cell transplantation." Russian journal of hematology and transfusiology 67, no. 1 (2022): 90–107. http://dx.doi.org/10.35754/0234-5730-2022-67-1-90-107.

Pełny tekst źródła
Streszczenie:
Introduction. Infections are among the most common complications after allogeneic hematopoietic stem cell transplantation.Aim — to provide a literature review on the main characteristics of infectious complications after allogenic hematopoietic stem cell transplantation and risk factors for their development.Main findings. Apart from direct factors such as neutropenia, hypogammaglobulinemia, and lymphopenia, there are indirect transplant-related factors such as conditioning regimen, transplant source, donor type, and graft-versus-host disease prophylaxis associated with higher infectious risk
Style APA, Harvard, Vancouver, ISO itp.
9

González, Marino J., Elena Urizar, Maider Urtaran-Laresgoiti, et al. "Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experience of care and costs." PLOS ONE 16, no. 8 (2021): e0254135. http://dx.doi.org/10.1371/journal.pone.0254135.

Pełny tekst źródła
Streszczenie:
The number of Hematopoietic Stem Cell Transplantations has risen in the past 20 years. The practice of outpatient Hematopoietic Stem Cell Transplantation programs is increasing in an attempt to improve the quality of patient care and reduce the demand for hospital admission. A systematic review of 29 comparative studies between in-hospital and outpatient treatment of Hematopoietic Stem Cell Transplantation, with no restriction by outpatient regime was conducted. This study aims to analyse the current evidence on the effects of the outpatient model on patient-centred outcomes, comparing both in
Style APA, Harvard, Vancouver, ISO itp.
10

Spexoto, Maria Cláudia Bernardes, and Maria Rita Marques de Oliveira. "One-hundred days monitoring patients submitted to hematopoietic stem cell transplantation: Events of metabolic syndrome." Revista de Ciências Médicas 23, no. 1 (2014): 25. http://dx.doi.org/10.24220/2318-0897v23n1a2412.

Pełny tekst źródła
Streszczenie:
ObjectiveThis study assessed early manifestations of metabolic syndrome determinants in patients submitted to hematopoietic stem cell transplantation.MethodsTwenty-seven individuals participated in the study (20 with autologous and 7 with allogeneic hematopoietic stem cell transplantation). Anthropometric variables and biochemical indicators of lipid and glucose metabolism were determined before and 100 days after hematopoietic stem cell transplantation.ResultsThe mean total cholesterol (p=0.086), very low density lipoprotein-cholesterol (p=0.069) and triglycerides (p=0.086) of all patients di
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Allogeneic hematopoietic cell transplantation"

1

Omazic, Brigitta. "Immune reconstitution after allogeneic hematopoietic stem cell transplantation /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7140-117-2/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Onda, Yoshiyuki. "Adenovirus infection after allogeneic hematopoietic stem cell transplantation." Doctoral thesis, Kyoto University, 2021. http://hdl.handle.net/2433/265191.

Pełny tekst źródła
Streszczenie:
京都大学<br>新制・課程博士<br>博士(医学)<br>甲第23419号<br>医博第4764号<br>新制||医||1052(附属図書館)<br>京都大学大学院医学研究科医学専攻<br>(主査)教授 滝田 順子, 教授 杉田 昌彦, 教授 朝長 啓造<br>学位規則第4条第1項該当<br>Doctor of Medical Science<br>Kyoto University<br>DFAM
Style APA, Harvard, Vancouver, ISO itp.
3

Aboalela, Ali Anwar. "Immune Reconstitution of B Cells Following Allogeneic Hematopoietic Cell Transplantation." Thesis, Harvard University, 2015. http://nrs.harvard.edu/urn-3:HUL.InstRepos:17331949.

Pełny tekst źródła
Streszczenie:
Objectives: Graft versus host disease (GVHD), infections and disease relapse continue to be major complications of allogeneic hematopoietic cell transplantation (HCT). B cell abnormalities have been associated with these complications, and the objective of these studies was to identify and quantify abnormalities of B cell recovery after allogeneic HCT. Methods: Flow cytometry was used to analyze peripheral blood from healthy donors (HD) and samples obtained at 1, 2, 3, 6, 9, 12, 18, 24, 30, and 36 months post HCT. A panel of 8 fluorophore-conjugated monoclonal antibodies specific for B cell su
Style APA, Harvard, Vancouver, ISO itp.
4

Okas, Mantas. "Novel immunotherapeutical strategies in allogeneic hematopoietic stem cell transplantation /." Stockholm : Department of laboratory medicine, Karolinska institutet, 2010. http://diss.kib.ki.se/2010/978-91-7409-934-8/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Wang, Fu-Zhang. "Human herpesvirus 6 infection after allogeneic stem cell transplantation /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3589-0/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Al-Ali, Haifa Kathrin. "The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation." Doctoral thesis, Universitätsbibliothek Leipzig, 2015. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-171123.

Pełny tekst źródła
Streszczenie:
Through the recruitment of immunologic mechanisms, allogeneic hematopoeitic cell transplantation (HCT) has been establiched as a curative treatment for various hematologic diseases. The most convenient source to obtain hematopoietic progenitor cells are peripheral blood stem cells (PBSCs) which are harvested from the donor via leukapheresis after mobilization with granulocyte-colony stimulating factors. With the introduction of reduced intensity condition (RIC), the curative potential of allogeneic HCT became accessible to older and/or frail patients otherwise ineligible for HCT. However, new
Style APA, Harvard, Vancouver, ISO itp.
7

Rascon, Jelena. "Chimerism analysis in isolated cell populations after allogeneic hematopoietic stem cell transplantation in children." Doctoral thesis, Lithuanian Academic Libraries Network (LABT), 2009. http://vddb.library.lt/obj/LT-eLABa-0001:E.02~2009~D_20090526_111155-01916.

Pełny tekst źródła
Streszczenie:
The doctoral thesis aimed to evaluate in a comparative way the benefit chimerism assessment in isolated cell populations (ICP) versus conventional monitoring in whole blood cells (WBC). The study was initiated in Pediatric Bone Marrow Transplant Service of Charité Children’s Hospital (Humboldt University, Berlin). Children suffered from: acute lymphoblastic leukemia (ALL), Fanconi anemia (FA) and adrenoleukodystrophy (ALD) were included into the study. Thereafter the doctoral thesis was accomplished at the Vilnius University where evaluation of the own experience of chimerism analysis in pedia
Style APA, Harvard, Vancouver, ISO itp.
8

Mattsson, Jonas. "Molecular monitoring of engraftment and leukemia relapse after allogeneic hematopoietic stem cell transplantation /." Stockholm, 2001. http://diss.kib.ki.se/2001/91-628-4757-0/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Thiede, Christian, Martin Bornhäuser, and Gerhard Ehninger. "Strategies and Clinical Implications of Chimerism Diagnostics after Allogeneic Hematopoietic Stem Cell Transplantation." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-137505.

Pełny tekst źródła
Streszczenie:
Analysis of donor chimerism has become a routine method for the documentation of engraftment after allogeneic hematopoietic stem cell transplantation (HSCT). In recent years several groups have also focused on the application of this technique for the detection of relapsing disease after allogeneic HSCT. This review addresses technical issues (sensitivity, specificity) and discusses the advantages and limitations of methods currently used for chimerism analysis and their usefulness for the detection of MRD. In addition, the potential impact of novel procedures, e.g. subset chimerism or real-ti
Style APA, Harvard, Vancouver, ISO itp.
10

Thiede, Christian, Martin Bornhäuser, and Gerhard Ehninger. "Strategies and Clinical Implications of Chimerism Diagnostics after Allogeneic Hematopoietic Stem Cell Transplantation." Karger, 2004. https://tud.qucosa.de/id/qucosa%3A27736.

Pełny tekst źródła
Streszczenie:
Analysis of donor chimerism has become a routine method for the documentation of engraftment after allogeneic hematopoietic stem cell transplantation (HSCT). In recent years several groups have also focused on the application of this technique for the detection of relapsing disease after allogeneic HSCT. This review addresses technical issues (sensitivity, specificity) and discusses the advantages and limitations of methods currently used for chimerism analysis and their usefulness for the detection of MRD. In addition, the potential impact of novel procedures, e.g. subset chimerism or real-ti
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Allogeneic hematopoietic cell transplantation"

1

Burt, Richard K., and Mary M. Brush, eds. Advances in Allogeneic Hematopoietic Stem Cell Transplantation. Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-4987-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

M, Brush Mary, and Burt Richard K. 1956-, eds. Advances in allogeneic hematopoietic stem cell transplantation. Kluwer Academic, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Laughlin, Mary J., and Hillard M. Lazarus. Allogeneic Stem Cell Transplantation. Humana Press, 2002. http://dx.doi.org/10.1385/159259333x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Lazarus, Hillard M., and Mary J. Laughlin, eds. Allogeneic Stem Cell Transplantation. Humana Press, 2010. http://dx.doi.org/10.1007/978-1-59745-478-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Laughlin, Mary J., and Hillard M. Lazarus, eds. Allogeneic Stem Cell Transplantation. Humana Press, 2003. http://dx.doi.org/10.1007/978-1-59259-333-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

J, Forman Stephen, Blume Karl G, and Thomas E. Donnall, eds. Hematopoietic cell transplantation. 2nd ed. Blackwell Science, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Blume, Karl G., Stephen J. Forman, and Frederick R. Appelbaum, eds. Thomas' Hematopoietic Cell Transplantation. Blackwell Publishing Ltd, 2003. http://dx.doi.org/10.1002/9780470987070.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Soiffer, Robert J., ed. Hematopoietic Stem Cell Transplantation. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-438-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Bishop, Michael R., ed. Hematopoietic Stem Cell Transplantation. Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-78580-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Forman, Stephen J., Robert S. Negrin, Joseph H. Antin, and Frederick R. Appelbaum, eds. Thomas’ Hematopoietic Cell Transplantation. John Wiley & Sons, Ltd, 2015. http://dx.doi.org/10.1002/9781118416426.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Allogeneic hematopoietic cell transplantation"

1

Appelbaum, Frederick R. "Hematopoietic Stem Cell Transplantation." In Allogeneic Stem Cell Transplantation. Humana Press, 2003. http://dx.doi.org/10.1007/978-1-59259-333-0_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Bornhäuser, Martin. "Allogeneic Hematopoietic Cell Transplantation." In Acute Myeloid Leukemia. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-72676-8_13.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Keever-Taylor, Carolyn A. "Immune Reconstitution after Allogeneic Transplantation." In Hematopoietic Stem Cell Transplantation. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-438-4_18.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Sandmaier, Brenda M., and Rainer Storb. "Reduced-intensity Allogeneic Transplantation Regimens." In Thomas’ Hematopoietic Cell Transplantation. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118416426.ch21.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Gaziev, Javid, and Guido Lucarelli. "Hematopoietic Stem Cell Transplantation for Thalassemia." In Allogeneic Stem Cell Transplantation. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-478-0_28.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Cutler, Corey. "Stem Cell Sources for Allogeneic Transplantation." In Hematopoietic Stem Cell Transplantation. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-438-4_12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Verneris, Michael R., and Jeffrey S. Miller. "Natural Killer Cells and Allogeneic Hematopoietic Cell Transplantation." In Thomas’ Hematopoietic Cell Transplantation. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118416426.ch11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Weisdorf, Daniel Daniel. "Allogeneic Unrelated Donor Blood and Marrow Transplantation." In Hematopoietic Stem Cell Transplantation. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-438-4_13.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Schmitz, Norbert, and Peter Dreger. "Peripheral Blood Hematopoietic Cells for Allogeneic Transplantation." In Thomas’ Hematopoietic Cell Transplantation. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118416426.ch41.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Ljungman, Per. "Viral Infections in Hematopoietic Stem Cell Transplant Recipients." In Allogeneic Stem Cell Transplantation. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-478-0_29.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Allogeneic hematopoietic cell transplantation"

1

Bergeron, Anne, Cendrine Godet, Sylvie Chevret, et al. "Bronchial Disorders After Allogeneic Hematopoietic Stem Cell Transplantation." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4666.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Lahzami, S., R. Schoeffel, C. Reid, et al. "Peripheral Airway Function Declines Following Allogeneic Hematopoietic Stem Cell Transplantation." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a5081.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Gazourian, Lee, Angela J. Rogers, Ruby Ibanga, et al. "Cytokine Profile In Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a6342.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Salvator, H., H. Vicaire, E. Cardot, et al. "Respiratory Infection with Non-Tuberculous Mycobacteria After Allogeneic Hematopoietic Stem Cell Transplantation." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2047.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

rivaud, elisabeth, Colas Tcherakian, Anne-cecile Metivier, et al. "Imatinib Mesylate (Gleevec®) And Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4662.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

van den Brink, Marcel. "Abstract IA22: The role of the intestinal microbiome in allogeneic hematopoietic cell transplantation." In Abstracts: AACR Special Conference on the Microbiome, Viruses, and Cancer; February 21-24, 2020; Orlando, FL. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.mvc2020-ia22.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Wenger, D., M. Triplette, K. A. Crothers, et al. "Incidence, Risk Factors and Outcomes of Idiopathic Pneumonia Syndrome After Allogeneic Hematopoietic Cell Transplantation." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5978.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Bargi, Gulsah, Meral Bosnak Guclu, Sahika Zeynep Aki, and Gulsan Turkoz Sucak. "Maximal exercise capacity and quality of life in allogeneic hematopoietic stem cell transplantation recipients." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa2571.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Hostettler Haack, Katrin Esther, Jörg Halter, and Michael Tamm. "Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa3923.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Frey, J., and K. Brownback. "Bronchoscopic Features, Associations and Outcomes of Organizing Pneumonia Following Allogeneic Hematopoietic Stem Cell Transplantation." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3673.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Allogeneic hematopoietic cell transplantation"

1

Wu, Xiaojin, Xiao Ma, Tiemei Song, Jie Liu, Yi Sun, and Depei Wu. Evidence Map for the Indirect Effects of CMV Infection on Patients with Allogeneic Hematopoietic Stem Cell transplantation. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0032.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Kungwankiattichai, Smith, Ben Ponvilawa, Claudie Roy, Pattaraporn Tunsing, Florian Kuchenbauer, and Weerapat Owattanapanich. Maintenance with Hypomethylating Agents after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.11.0078.

Pełny tekst źródła
Streszczenie:
Review question / Objective: P: Patients with AML or MDS after allo-SCT; I: Hypomethylating agents after allo-SCT; C: Observation after allo-SCT; O: Overall survival rates. Condition being studied: Hypomethylating agents (HMAs) seem to have a range of properties favorable to post-allogeneic hematopoietic stem cell transplantation (allo-SCT) maintenance in acute myeloid leukemia (AML) patients. This meta-analysis was performed to review all relevant studies to compare the outcomes of patients undergoing allo-SCT for AML or MDS receiving HMA maintenance therapy with observation only. Information
Style APA, Harvard, Vancouver, ISO itp.
3

Zhang, Guanghui, Baoyu Li, and Hongyan Wu. Autologous or allogeneic hematopoietic stem cells transplantation combined with high-dose chemotherapy for refractory neuroblastoma: a systematic review and meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.12.0092.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

ZHAO, ZHANGSHUAI, WEI SHAO, and JIKE LIU. Autologous or allogeneic hematopoietic stem cells transplantation combined with high-dose chemotherapy for refractory neuroblastoma: a systematic review and meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.11.0007.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Reshef, Ran. Chemokine Receptor Signatures in Allogeneic Stem Cell Transplantation. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada610688.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Reshef, Ran. Chemokine Receptor Signatures in Allogeneic Stem Cell Transplantation. Defense Technical Information Center, 2015. http://dx.doi.org/10.21236/ada620593.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Abel, Gregory, Haesook Kim, Thomas Walsh, Vincent Ho, and Robert Soiffer. Shared Care: Patient-Centered Management after Hematopoietic Cell Transplantation. Patient-Centered Outcomes Research Institute (PCORI), 2024. http://dx.doi.org/10.25302/09.2024.ihs.151133081.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Lew, Chong Zhi, and Ting Chi Yeh. Pediatric Extracranial Germ Cell Tumor: Clinical Perspective of Autologous Hematopoietic Cell Transplantation. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.1.0081.

Pełny tekst źródła
Streszczenie:
Review question / Objective: A large number of systematic reviews and meta-analyses (SRs/MAs) involving sodium-glucose cotransporter-2 inhibitors (SGLT-2is) in the treatment of heart failure with preserved ejection fraction (HFpEF) have different outcomes. Condition being studied: The efficacy of SGLT-2is on HFpEF is currently a hot topic. However, the results of SRs/MAs conducted on relevant randomized controlled trials (RCTs) are inconsistent. We aim to conduct an umbrella review of existing SRs/MAs, to comprehensively evaluate study quality, and to incorporate calculated data from RCTs to u
Style APA, Harvard, Vancouver, ISO itp.
9

Graves, Scott S., Rainer Storb, Bradley Stone, and Beatrice Knudsen. Adoptive Immunotherapy Combined with Hematopoietic Cell Transplantation as a Therapeutic Approach to Treatment of Prostate Cancer. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada501663.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Liu, Huan, Hui Huang, Jia Guo, et al. Effects of aerobic exercise on fatigue in patients with hematopoietic stem cell transplantation: a meta analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.5.0110.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Allogeneic hematopoietic cell transplantation” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii